ClinConnect ClinConnect Logo
Search / Trial NCT06256809

Analyzing Handprint Patterns to Predict Oral Cancer Risks: A Comparative Study

Launched by KING KHALID UNIVERSITY · Feb 11, 2024

Trial Information

Current as of July 27, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial, titled "Analyzing Handprint Patterns to Predict Oral Cancer Risks," is studying how the patterns on our fingers and palms might help predict the risk of oral cancer, specifically in people with conditions like Oral Leukoplakia. The researchers aim to compare these handprint patterns between different groups of patients: some who have precancerous or cancerous oral lesions, some who have a history of chewing tobacco or areca nut but do not have any lesions, and some healthy individuals without these habits. By analyzing these patterns, the study hopes to find out if there are certain handprint features that are more common in those with oral cancer risks.

To be eligible for this study, participants should be diagnosed with conditions like Oral Leukoplakia, Oral Submucous Fibrosis, or Oral Squamous Cell Carcinoma and be willing to take part. However, individuals with other health issues that could affect handprint patterns or those who have received treatments that might change these patterns cannot participate. If you join the study, you can expect to have your fingerprints and palm prints taken using a simple ink method, and your patterns will be analyzed to see if there are any significant differences between the groups. This research could potentially lead to better ways to identify individuals at higher risk for oral cancer.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Individuals diagnosed with specific oral conditions such as Oral Leukoplakia, Oral Submucous Fibrosis, or Oral Squamous Cell Carcinoma.
  • Individuals willing to participate in the study.
  • Exclusion Criteria:
  • Individuals with systemic diseases that could affect dermatoglyphic patterns.
  • Individuals who have undergone treatments that could alter palmar or plantar patterns.

About King Khalid University

King Khalid University, a prominent academic institution located in Abha, Saudi Arabia, is dedicated to advancing medical research and healthcare through innovative clinical trials. With a focus on enhancing patient outcomes and contributing to the global body of medical knowledge, the university leverages its state-of-the-art facilities and a collaborative network of experts. King Khalid University is committed to upholding the highest ethical standards and regulatory compliance in its clinical research endeavors, aiming to foster advancements in various medical fields while ensuring the safety and well-being of participants.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported